FOLFIRINOX as First-line Chemotherapy in Japanese Patients Suffering from Metastatic Pancreatic Cancer (KOBE FOLFIRINOX Study).

Saved in:
Bibliographic Details
Title: FOLFIRINOX as First-line Chemotherapy in Japanese Patients Suffering from Metastatic Pancreatic Cancer (KOBE FOLFIRINOX Study).
Authors: Hatachi Y; Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe, Japan.; Department of Clinical Oncology, Kansai Rosai Hospital, Amagasaki, Japan., Mohan SR; Department of Artificial Intelligence, AI Medical and Health Tech Systems, Osaka, Japan., Kotake T; Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe, Japan.; Department of Clinical Oncology, Kansai Electric Power Hospital, Osaka, Japan., Satake H; Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe, Japan.; Cancer Treatment Center, Kansai Medical University Hospital, Hirakata, Japan., Okita Y; Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe, Japan.; Department of Clinical Oncology, Kagawa University Hospital, Kagawa, Japan., Yasui H; Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe, Japan., Tsuji A; Department of Medical Oncology, Kobe City Medical Center General Hospital, Kobe, Japan.; Department of Clinical Oncology, Kagawa University Hospital, Kagawa, Japan.
Source: Cancer diagnosis & prognosis [Cancer Diagn Progn] 2022 Jan 03; Vol. 2 (1), pp. 101-106. Date of Electronic Publication: 2022 Jan 03 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: International Institute of Anticancer Research Country of Publication: Greece NLM ID: 9918316186306676 Publication Model: eCollection Cited Medium: Internet ISSN: 2732-7787 (Electronic) Linking ISSN: 27327787 NLM ISO Abbreviation: Cancer Diagn Progn Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2732-7787
DOI:10.21873/cdp.10083